Study guide
12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT
Registered Cardiac Electrophysiology Specialist RCES
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pre-Procedural Assessment & Patient Preparation
1.1 Procedure Room Preparation, Equipment Verification & Aseptic Readiness 1.2 Pre-Procedural Clinical Evaluation, Labs, Consents & The Universal Time-Out 1.3 Patient Identification, Transport, HIPAA & Procedural Documentation 1.4 Patient Monitoring Setup, Defibrillator Pads & Pre-Procedural CIED Interrogation 1.5 Vascular Access Planning, Skin Preparation & Sterile Draping
2 Chapter 2: Cardiac Anatomy, Conduction & Electrophysiologic Foundations
2.1 Cardiac Anatomy for the EP Lab: Chambers, Access Routes & Coronary Supply 2.2 The Cardiac Conduction System, Action Potentials & Ion Channel Physiology 2.3 Cardiac Vector Analysis, 12-Lead ECG Fundamentals & Axis Determination
3 Chapter 3: EP Lab Instrumentation, Connectology & Lab Safety
3.1 EP Recording System Architecture, Signal Amplification & Frequency Filters 3.2 Cardiac Stimulator Operation, Junction Box Routing & Noise Troubleshooting 3.3 Electrical Safety, Electrical Units, Electrocautery & Fire Safety 3.4 Radiation Safety Physics, ALARA Principles, Shielding & Dose Limits 3.5 Procedural Supplies, Catheter Inventory, Surgical Instrumentation & Wound Closure
4 Chapter 4: Intra-Procedural Imaging, Sedation & Physiologic Monitoring
4.1 Fluoroscopic Projections (RAO, LAO, AP) & X-ray Tube Optimization 4.2 Intracardiac Echocardiography (ICE) Principles, Views & Catheter Navigation 4.3 Non-Radiographic Imaging: Cardiac CT/MRI, Image Fusion & Ultrasound-Guided Access 4.4 Conscious Sedation Protocols, Airway Management & Hemodynamic Monitoring 4.5 Vital Signs, Normal Laboratory Values & Intra-Procedural Lab Monitoring
5 Chapter 5: EP Pharmacology, Anticoagulation & Emergency Drugs
5.1 Vaughan Williams Antiarrhythmic Classification & EP Electrophysiology 5.2 Diagnostic & Provocative Drugs: Adenosine, Isoproterenol, Epinephrine, Atropine 5.3 Sedation & Analgesia Pharmacology, Reversal Agents & Recovery Scoring 5.4 Heparin Protocol, ACT Monitoring & Emergency Reversal with Protamine 5.5 Oral Anticoagulants, Antiplatelets & Peri-Procedural Management 5.6 ACLS Algorithms & Emergency Medications in the EP Lab
6 Chapter 6: Catheter Navigation, Normal Electrograms & Baseline Intervals
6.1 Standard Diagnostic Catheter Positions & Fluoroscopic/Anatomical Landmarks 6.2 Intracardiac Electrogram Interpretation & Normal Baseline Intervals (PA, AH, HV) 6.3 His Bundle Electrogram Recording, Split His Potentials & Infranodal Conduction
7 Chapter 7: Programmed Electrical Stimulation & Refractory Periods
7.1 Pacing Stimulation Fundamentals, Capture Thresholds & Drive Trains 7.2 Refractory Period Determination (ERP, RRP, FRP) & Sinus Node Function Testing (SNRT, cSNRT) 7.3 AV Nodal Decremental Conduction & Dual AV Nodal Physiology
8 Chapter 8: Diagnostic Evaluation of Supraventricular & Ventricular Tachycardias
8.1 Narrow-Complex Tachycardias: Differential Diagnosis of AVNRT, AVRT & AT 8.2 Diagnostic Pacing Maneuvers: Entrainment, PPI-TCL, V-A-V vs V-A-A-V & His-Refractory PVCs 8.3 Wide-Complex Tachycardias & Ventricular Arrhythmia Mapping Criteria
9 Chapter 9: Bradyarrhythmias, AV Block & Atrial Arrhythmia Recognition
9.1 Bradyarrhythmias, AV Block Classification & Conduction System Disease 9.2 Atrial Fibrillation & Atrial Flutter: Classification, ECG Recognition & Stroke Risk
10 Chapter 10: 3D Electroanatomic Mapping & Ablation Biophysics
10.1 3D Electroanatomic Mapping Systems (Carto, EnSite, Rhythmia) Setup & Troubleshooting 10.2 Activation, Propagation & Bipolar Voltage Substrate Mapping 10.3 Ablation Biophysics: Radiofrequency, Cryoablation & Pulsed Field Ablation (PFA)
11 Chapter 11: Transseptal Access, Catheter Ablation Targets & Endpoints
11.1 Transseptal Puncture: Anatomy, Technique, Imaging Guidance & Complications 11.2 Catheter Ablation of AVNRT Slow Pathway & Accessory Pathways (WPW) 11.3 Cavotricuspid Isthmus (CTI) Ablation for Typical Atrial Flutter 11.4 Pulmonary Vein Isolation (PVI) for AFib & Ventricular Tachycardia Ablation
12 Chapter 12: Cardiac Implantable Electronic Devices: Implantation & Testing
12.1 Pacemaker & Transvenous ICD Implantation Techniques & Safety 12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT 12.3 Cardiac Resynchronization Therapy (CRT) & Conduction System Pacing (HBP, LBBAP)
13 Chapter 13: CIED Interrogation, Programming & Troubleshooting
13.1 NBG Pacemaker Codes, Pacing Modes & Timing Cycles 13.2 CIED Interrogation Workflow, Programmer Operation & Peri-Procedural Reprogramming 13.3 Interpreting & Conveying Interrogated Data: Diagnostics, Counters & Stored Episodes 13.4 Pacing & Sensing Malfunctions, Electromagnetic Interference & Temporary Pacing
14 Chapter 14: Specialized Devices, Extraction & Acute Procedural Emergencies
14.1 Subcutaneous ICD (S-ICD), Leadless Pacemakers & Left Atrial Appendage Closure 14.2 Transvenous Lead Extraction Tools, Techniques & Safety Precautions 14.3 Acute Procedural Emergencies: Perforation, Tamponade, Pericardiocentesis & Air Embolism
15 Chapter 15: Post-Procedural Care, Hemostasis & Complication Management
15.1 Femoral Hemostasis Techniques: Manual Compression, Figure-of-8 & Closure Devices 15.2 Post-Procedural Complications: Vascular Injury, AV Block, Esophageal Injury & Neurologic Deficits 15.3 Post-Procedural CIED Assessment, Device Follow-Up & Wound Care 15.4 Post-Procedure Patient Recovery, Discharge Education & Clinical Handover
12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT
Key Takeaways Explain This Topic AI
Pacing System Analyzer (PSA) connectology requires attaching the black cathode (-) clip to the distal lead pin and the red anode (+) clip to the proximal ring; reversing connections causes anodal pacing, falsely elevating capture thresholds by 20% to 50%.
Intra-procedural sensing criteria require intrinsic P-wave amplitudes ≥ 1.5 to 2.0 mV (slew rate > 0.5 V/s) and R-wave amplitudes ≥ 5.0 mV (target > 7 to 10 mV, slew rate > 0.75 to 1.0 V/s); active helix deployment must demonstrate a prominent Current of Injury (COI).
Acute pacing capture thresholds must be < 1.0 to 1.5 V at 0.5 ms in the atrium and < 0.8 to 1.0 V at 0.5 ms in the ventricle, with permanent device outputs programmed to at least double the voltage threshold or triple the pulse width threshold.
Normal pacing lead impedance ranges from 300 to 1,000 Ω; an impedance spike (> 1,500 to 2,000 Ω) signals conductor coil fracture, loose set screws, or incomplete pin seating, whereas an impedance drop (< 200 to 300 Ω) indicates outer or inner insulation breach.
Contemporary randomized trials (SIMPLE, NORDIC) confirm that routine defibrillation threshold (DFT) testing is unnecessary in standard transvenous implants with high-output generators (≥ 35 to 40 J), remaining indicated primarily for right-sided implants, subcutaneous systems, or complex congenital anatomy.
Last updated: September 2026
12.2 Intra-Procedural Electrical Testing: Sensing, Pacing Thresholds, Impedance & DFT
Intra-procedural electrical testing of newly implanted transvenous leads confirms mechanical stability, validates electrical coupling with viable myocardium, and verifies device safety margins before securing leads in the surgical pocket. Utilizing a Pacing System Analyzer (PSA), the electrophysiology specialist systematically evaluates intrinsic signal sensing, pacing capture thresholds, lead impedance, and diaphragmatic stimulation.
Pacing System Analyzer (PSA) Setup & Sterile Connectology
The Pacing System Analyzer (PSA) is a precision external diagnostic pacing computer interfaced with the sterile surgical field via reusable or disposable touch-proof cables.
Sterile Cable Polarity & Connectology Rules
Lead cables terminate in color-coded alligator clips or sterile pin adaptors. Proper connectology is governed by strict biophysical conventions:
Distal Terminal (Cathode / Negative Pole) : Must always be connected to the Black clip ( − - − ). On an IS-1 or DF4 connector pin, the distal metallic tip corresponds to the negative exploring cathode.
Proximal Terminal (Anode / Positive Pole) : Must always be connected to the Red clip ( + + + ). On an IS-1 bipolar lead, the proximal metallic ring corresponds to the positive anode.
Consequences of Reversed Polarity : If clips are inadvertently transposed (Red clip to tip, Black clip to ring), pacing current emanates from the ring into the myocardial cavity while the tip functions as an anode. Anodal pacing requires significantly higher electrical energy to initiate depolarization, falsely elevating measured voltage thresholds by 20% to 50%. Furthermore, anodal break excitation can induce timing distortions on recorded electrograms.
Lead Connector Standards (IS-1, DF-1, DF4)
IS-1 (International Standard 1) : The universal 3.2-mm pacing and sensing lead connector standard. Features a distal terminal pin (cathode) and a proximal cylindrical ring (anode) separated by two flexible silicone sealing rings that prevent fluid ingress into the generator header.
DF-1 (Defibrillator 1) : Legacy high-voltage connector standard. A dual-coil ICD lead required three separate connector pins: one IS-1 pin for pacing/sensing, one DF-1 pin for the RV shocking coil, and a second DF-1 pin for the SVC shocking coil. Header misconnection and pin confusion were frequent failure modes.
DF4 Standard : Modern unified 4-pole high-voltage connector standard (ISO 27186). Combines ventricular pacing/sensing (tip cathode, ring anode) and high-voltage shocking (RV coil, SVC coil) into a single connector pin incorporating four distinct contact rings isolated by internal silicone seals. DF4 eliminates the bulky generator header, reduces pocket volume, and eliminates lead port transposition errors.
Intrinsic Sensing Measurements & Current of Injury (COI)
Accurate sensing prevents competitive pacing and pacemaker-mediated arrhythmias while ensuring rapid detection of malignant ventricular tachyarrhythmias.
Amplitude & Slew Rate Criteria
During testing, the PSA filter is configured to match standard device sensing filters (typically a bandpass of 15 to 40 Hz high-pass and 100 to 300 Hz low-pass). The PSA displays peak-to-peak electrogram amplitude and maximum slew rate:
Atrial P-Wave : Minimum acceptable amplitude is ≥ 1.5 to 2.0 mV \ge 1.5\text{ to }2.0\text{ mV} ≥ 1.5 to 2.0 mV (ideal target ≥ 2.5 to 4.0 mV \ge 2.5\text{ to }4.0\text{ mV} ≥ 2.5 to 4.0 mV ) during sinus rhythm. Slew rate must exceed > 0.5 V/s > 0.5\text{ V/s} > 0.5 V/s .
Ventricular R-Wave : Minimum acceptable amplitude is ≥ 5.0 mV \ge 5.0\text{ mV} ≥ 5.0 mV (ideal target > 7.0 to 10.0 mV > 7.0\text{ to }10.0\text{ mV} > 7.0 to 10.0 mV , with pristine septal sites often exceeding 15 mV). Slew rate must exceed > 0.75 to 1.0 V/s > 0.75\text{ to }1.0\text{ V/s} > 0.75 to 1.0 V/s .
Slew Rate ( d V / d t dV/dt d V / d t ) Biophysics : Slew rate represents the rate of change of voltage over time, mathematically defined as the first derivative of the electrogram ( d V / d t dV/dt d V / d t ). High slew rates reflect sharp, high-frequency local myocardial activation. Devices utilize slew rate filtering to distinguish near-field depolarizations from broad, low-frequency far-field repolarization waves (such as T-waves, which have low d V / d t dV/dt d V / d t ). Intrinsic Ventricular Depolarization (R-Wave):
- +10 mV | /\
- | / \
- | / \
- 0 mV |------/------\------- (Steep dV/dt > 1.0 V/s)
- | / \
- 5 mV | / \/
- The Current of Injury (COI)
When an active-fixation helical screw penetrates the myocardial endocardium, localized mechanical cellular membrane disruption occurs. Intracellular potassium leaks into the interstitial space, creating a persistent localized electrical potential difference between injured and healthy myocardium.
On the unipolar or bipolar PSA electrogram, this localized trauma manifests as marked ST-segment elevation , designated the Current of Injury (COI) :
Atrial COI Acceptance : ST elevation of ≥ 1.5 to 2.0 mV \ge 1.5\text{ to }2.0\text{ mV} ≥ 1.5 to 2.0 mV , or an ST-segment shift exceeding 25 % 25\% 25% to 50 % 50\% 50% of the intrinsic P-wave height.
Ventricular COI Acceptance : ST elevation of ≥ 5.0 to 10.0 mV \ge 5.0\text{ to }10.0\text{ mV} ≥ 5.0 to 10.0 mV , or an ST-segment shift exceeding 25 % 25\% 25% to 50 % 50\% 50% of the intrinsic R-wave height, accompanied by a dynamic broadening of the electrogram duration ( > 20 ms > 20\text{ ms} > 20 ms widening).
Predictive Clinical Value : A robust COI serves as definitive electrophysiological proof of adequate myocardial engagement. Clinical studies demonstrate that leads exhibiting brisk COI immediately post-fixation achieve lower acute and chronic pacing thresholds, maintain superior chronic R-wave sensing, and experience near-zero rates of micro-dislodgement. Conversely, a lead showing acceptable R-wave amplitude but no COI is likely floating in the blood pool, touching fibrous scar tissue, or superficially apposed without helix penetration, predisposing to late dislodgement.
Pacing Capture Thresholds & Safety Margins
The pacing threshold is the minimal electrical energy required to consistently trigger a propagated myocardial action potential outside tissue refractoriness.
Voltage Threshold Determination
Testing is performed at a standardized pulse duration (pulse width), standardly fixed at 0.5 ms 0.5\text{ ms} 0.5 ms (near the chronaxie of cardiac tissue). The voltage output is stepped down in 0.1-V increments until 1 : 1 1:1 1 : 1 capture is lost:
Atrial Acceptance Threshold : < 1.0 to 1.5 V at 0.5 ms < 1.0\text{ to }1.5\text{ V at }0.5\text{ ms} < 1.0 to 1.5 V at 0.5 ms (target < 0.8 V < 0.8\text{ V} < 0.8 V ). An acute atrial threshold > 1.5 V > 1.5\text{ V} > 1.5 V warrants immediate repositioning.
Ventricular Acceptance Threshold : < 0.8 to 1.0 V at 0.5 ms < 0.8\text{ to }1.0\text{ V at }0.5\text{ ms} < 0.8 to 1.0 V at 0.5 ms (target < 0.5 to 0.6 V < 0.5\text{ to }0.6\text{ V} < 0.5 to 0.6 V at septal or apical sites).
Permanent Programming Safety Margins
To ensure capture throughout postural changes, exercise, metabolic shifts, and autonomic fluctuations, operational outputs must be programmed with an adequate safety margin:
Voltage Safety Margin : Program voltage output to 2 × the measured voltage threshold 2\times\text{ the measured voltage threshold} 2 × the measured voltage threshold at the same pulse width (e.g., if threshold is 0.7 V at 0.5 ms, program operational output to ≥ 1.5 to 2.0 V at 0.5 ms \ge 1.5\text{ to }2.0\text{ V at }0.5\text{ ms} ≥ 1.5 to 2.0 V at 0.5 ms ).
Pulse Width Safety Margin : If voltage is fixed, pulse duration must be programmed to 3 × the pulse width threshold 3\times\text{ the pulse width threshold} 3 × the pulse width threshold .
Automated Capture Algorithms : Contemporary CIEDs feature automated threshold algorithms (e.g., AutoCapture, Capture Management) that perform periodic beat-to-beat or daily automated threshold searches, automatically adjusting voltage output to maintain a constant 0.5 to 1.0 V 0.5\text{ to }1.0\text{ V} 0.5 to 1.0 V safety margin above threshold, maximizing patient safety while extending battery longevity to 10 to 14 years.
Lead Impedance Biophysics & Troubleshooting
Pacing lead impedance ( Z Z Z ) reflects total resistance to electrical current flow through the conductor coil, electrode-tissue interface, and surrounding body fluid ( Z = V I Z = \frac{V}{I} Z = I V ).
Normal Pacing Impedance Range
The normal physiological range for standard transvenous low-voltage pacing leads is 300 to 1 , 000 Ω 300\text{ to }1,000\text{ }\Omega 300 to 1 , 000 Ω (typically 400 to 800 Ω 400\text{ to }800\text{ }\Omega 400 to 800 Ω ).
Lead Condition Impedance Value Root Cause Clinical Presentation
Normal Pacing Lead 300 − 1 , 000 Ω 300 - 1,000\text{ }\Omega 300 − 1 , 000 Ω Intact conductor, sound insulation, stable contact Stable capture and sensing
High Impedance (Open Circuit) > 1 , 500 − 2 , 000 Ω > 1,500 - 2,000\text{ }\Omega > 1 , 500 − 2 , 000 Ω (or Out-of-Range > 3 , 000 Ω >3,000\text{ }\Omega > 3 , 000 Ω ) Conductor coil fracture, loose header set screw, unseated pin Intermittent or complete loss of capture; noise sensing
Low Impedance (Short Circuit) < 200 − 300 Ω < 200 - 300\text{ }\Omega < 200 − 300 Ω Outer/inner insulation breach, clavicular crush, friction wear Rapid battery depletion; capture loss if shunt is severe
Normal Shock Coil Lead 30 − 80 Ω 30 - 80\text{ }\Omega 30 − 80 Ω Large surface area high-voltage coil High-current shock delivery pathway intact
Abnormal Shock Lead < 20 Ω <20\text{ }\Omega < 20 Ω or > 100 − 110 Ω >100-110\text{ }\Omega > 100 − 110 Ω Coil insulation short circuit ( < 20 Ω <20\text{ }\Omega < 20 Ω ) or fractured coil ( > 100 Ω >100\text{ }\Omega > 100 Ω ) Risk of generator damage or failure to deliver shock
High Impedance Troubleshooting Algorithm
If the PSA or device reports impedance > 1 , 500 to 2 , 000 Ω > 1,500\text{ to }2,000\text{ }\Omega > 1 , 500 to 2 , 000 Ω :
Inspect Set Screws & Pin Depth : In a newly connected lead, the most common error is failure to fully insert the connector pin past the silicone header seal rings, or seating the torque wrench set screw into silicone rather than directly onto the metallic connector pin. Back out the screw, advance the pin until the tip is visible through the clear viewing window at the end of the header port, and re-torque until the wrench clicks.
Conductor Fracture : In a chronic lead, a sharp impedance spike accompanied by make-break electrical noise indicates a complete mechanical fracture of the conductor wire.
Low Impedance Troubleshooting Algorithm
If impedance drops below 200 to 300 Ω 200\text{ to }300\text{ }\Omega 200 to 300 Ω :
Insulation Breakdown : An insulation breach creates a low-resistance parallel pathway (short circuit), allowing current to leak directly into blood or interstitial fluid before reaching the lead tip. While pacing thresholds may initially appear normal, current delivery ( I = V R I = \frac{V}{R} I = R V ) increases dramatically, draining generator battery capacity in months.
Diaphragmatic & Phrenic Nerve Stimulation Testing
Pacing stimuli that inadvertently capture the phrenic nerve cause rhythmic, uncomfortable diaphragmatic contractions that severely disrupt patient quality of life and can mimic hiccups or chest jerks.
Anatomical Risk Zones
Right Phrenic Nerve : Courses along the anterolateral surface of the superior vena cava and right atrium, in close proximity to the right atrial appendage and lateral RA wall.
Left Phrenic Nerve : Courses along the fibrous pericardium immediately overlying the posterolateral and lateral left ventricular free wall, in direct contact with lateral tributaries of the coronary sinus used for CRT left ventricular leads.
RV Apical Perforation : If an RV lead tip inadvertently perforates the thin RV apex into the pericardial space, it directly abuts the left hemidiaphragm.
Intra-Procedural Testing Protocol
Before connecting leads to the generator, the operator must execute high-output safety pacing:
Program PSA output to maximum amplitude: 10.0 V 10.0\text{ V} 10.0 V at a wide pulse width ( 1.0 ms 1.0\text{ ms} 1.0 ms ) .
Pace at a rate faster than intrinsic rhythm (e.g., 80 to 100 bpm).
Instruct the patient to take a deep inspiratory breath and hold it (inspiration moves the diaphragm closer to the heart, maximizing potential phrenic nerve contact).
Simultaneously palpate the patient's epigastrium and lower thoracic rib cage while observing fluoroscopy for diaphragmatic twitching synchronous with pacing spikes.
If phrenic capture occurs, the lead must be repositioned, or in the case of quadripolar LV leads, an alternate non-capturing pacing vector must be selected.
Defibrillation Threshold (DFT) Testing: Contemporary Evidence & Protocols
Defibrillation threshold testing assesses the ability of an implanted ICD system to reliably detect ventricular fibrillation (VF) and deliver a successful termination shock with an acceptable energy safety margin. [Baseline Ventricular Pacing (8 beats)] ===> [T-Wave Shock (1-2 J on T-Wave Peak)]
- |
- v
- [VF Induced (Rate > 250 bpm)]
- |
- v
- [ICD Detection & Capacitor Charge]
- |
- v
- [Termination Shock Delivered (<= 30 J)]
- |
- v
- [Restoration of Sinus Rhythm]
- The Shift from Routine to Selective DFT Testing
Historically, induction of VF was considered mandatory for every ICD implant. However, landmark randomized clinical trials altered contemporary guidelines:
The SIMPLE Trial (2,500 patients) and NORDIC ICD Trial : Evaluated routine DFT testing versus no testing during transvenous ICD implantation. Both trials conclusively demonstrated that omitting DFT testing did not compromise first-shock efficacy for spontaneous ventricular arrhythmias or increase long-term arrhythmic mortality.
Procedural Risks of DFT Testing : Induced VF carries risks of hemodynamic collapse, transient cerebral hypoperfusion, ischemic stroke, anesthesia complications, acute worsening of heart failure, and refractory VF requiring multiple external rescue shocks.
Contemporary Indications for DFT Testing
Per Heart Rhythm Society (HRS) consensus guidelines, routine DFT testing is no longer recommended for straightforward transvenous left-pectoral ICD implants with high-energy generators ( > 35 to 40 J > 35\text{ to }40\text{ J} > 35 to 40 J ). Testing remains indicated in specific clinical scenarios:
Subcutaneous ICD (S-ICD) Implantation : Mandatory testing at 65 J to verify adequate shock coil-to-can vector coverage across the thoracic cage.
Right-Sided Pectoral or Abdominal Generator Implants : Altered shock vectors cross less left ventricular myocardial mass.
Hypertrophic Cardiomyopathy (HCM) : Massive myocardial hypertrophy increases defibrillation resistance.
Complex Congenital Heart Disease or Dextrocardia .
Suspected High Defibrillation Thresholds : Patients on chronic amiodarone therapy (which elevates DFT) or with borderline lead positions.
Induction Techniques & Safety Margin Criteria
Induction Methods :
T-Wave Shock : A low-energy synchronized shock ( 1.0 to 2.0 J 1.0\text{ to }2.0\text{ J} 1.0 to 2.0 J ) delivered directly onto the vulnerable peak or upslope of the T-wave during rapid ventricular pacing drive trains.
DC Fibber / High-Frequency Burst : Delivering a continuous 50-Hz electrical burst or 9-V direct current (DC) directly to the RV endocardium.
Safety Margin Acceptance Criteria : The induced arrhythmia must be sensed without delay (detection interval < 2.5 s < 2.5\text{ s} < 2.5 s ), capacitors must charge within specification ( < 10 to 15 s < 10\text{ to }15\text{ s} < 10 to 15 s ), and the initial internal shock must successfully terminate VF with at least a 10 -Joule safety margin 10\text{-Joule safety margin} 10 -Joule safety margin below the maximum programmable device output (e.g., successful termination at ≤ 30 J \le 30\text{ J} ≤ 30 J on a 40-J generator).